Keystone Financial Group (Kentucky)’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $21.9K | Buy |
24,700
+2,050
| +9% | +$1.82K | ﹤0.01% | 282 |
|
|
2022
Q3 | $36K | Hold |
22,650
| – | – | 0.01% | 281 |
|
|
2022
Q2 | $46K | Buy |
22,650
+2,500
| +12% | +$5.08K | 0.01% | 286 |
|
|
2022
Q1 | $47K | Buy |
20,150
+2,000
| +11% | +$4.67K | 0.01% | 287 |
|
|
2021
Q4 | $84K | Buy |
18,150
+1,000
| +6% | +$4.63K | 0.01% | 298 |
|
|
2021
Q3 | $131K | Buy |
17,150
+100
| +0.6% | +$764 | 0.02% | 282 |
|
|
2021
Q2 | $165K | Hold |
17,050
| – | – | 0.03% | 284 |
|
|
2021
Q1 | $141K | Buy |
17,050
+1,080
| +7% | +$8.93K | 0.03% | 280 |
|
|
2020
Q4 | $109K | Buy |
+15,970
| New | +$109K | 0.02% | 260 |
|